Skip to main content

Series D Biopharma Companies

Explore 10 biopharma startups that raised series d funding. Access verified founder contact information and fundraising data.

Total Companies
10
Total Funding
$1.3B
Avg Funding
$127.2M
Cities
8

Export 10 Series D Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cambridge, United States
$191.0M
raised

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Sep 2024
Series D

Founder Contacts

41,000+ verified contacts

San Diego, United States
$52.0M
raised

ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.

May 2026
Series D

Founder Contacts

41,000+ verified contacts

Tokyo, Japan
$7.9M
raised

Varinos is a biotechnology company that offers new genomic testing and contract analysis services.

May 2026
Series D

Founder Contacts

41,000+ verified contacts

Westlake Village, United States
$130.0M
raised

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Feb 2026
Series D

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$372.5M
raised

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Jul 2025
Series D

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 10 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$100.0M
raised

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Jul 2025
Series D

Founder Contacts

41,000+ verified contacts

Seattle, United States
$14.0M
raised

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

May 2023
Series D

Founder Contacts

41,000+ verified contacts

Chicago, United States
$270.0M
raised

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Nov 2022
Series D

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$115.0M
raised

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Nov 2025
Series D

Founder Contacts

41,000+ verified contacts

Woburn, United States
$20.0M
raised

Vertero Therapeutics is using cutting-edge research outside of the brain to treat neurodegenerative illnesses.

Oct 2025
Series D

Founder Contacts

41,000+ verified contacts

Ready to Connect with Series D Biopharma Startups?

Get verified founder emails, funding details, and company data for 10 series d biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked